Blueprint Medicines

BPMC · NASDAQ

Price unavailable right now.

No price history for this range.

About BPMC

Blueprint Medicines Corp. is a precision therapy company, which engages in the provision of medicines for people with cancer and blood disorders. The company is headquartered in Cambridge, Massachusetts and currently employs 682 full-time employees. The firm invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. The firm delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and PDGFRA Exon 18 mutant GIST in the United States and Europe. The company has a pipeline of research and development programs that range from early science to advanced clinical trials in mast cell-mediated diseases, including systemic mastocytosis (SM) and chronic urticaria, breast cancer, and other solid tumors vulnerable to CDK2 inhibition. Its pipeline includes Elenestinib (BLU-263), BLU-808, and BLU-956. The company is developing Elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders. The company is advancing BLU-808, a potent and selective wild-type KIT inhibitor, for mast cell diseases.

Employees: 649
Headquarters: Cambridge, Massachusetts
Listed: Apr 30, 2015
Sector: Health Care
Industry: Biotechnology
Website: blueprintmedicines.com

Leadership

Blueprint Medicines executives
Name	Title	Since	Age
Kathryn Haviland	—	2016	49
Michael Landsittel	—	—	53
Fouad Namouni	—	—	56
Christina Rossi	—	—	49
Debra Durso-Bumpus	—	—	55
Ariel Hurley	—	—	51
Percy Carter	—	—	54
Tracey Mccain	—	—	57
Becker Hewes	—	—	59
Philina Lee	—	2022	49
Michael Tolpa	—	—	—
Jenna Cohen	—	2023	—

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Blueprint Medicines suppliers and customers
Company	Relationship	Country	Correlation
Catalent CTLT	Supplier	US	0.88
Certara CERT	Supplier	US	0.87
CStone Pharmaceuticals	Supplier and customer	CN	0.72
Zai Lab	Supplier and customer	CN	0.52
Roche Holding ROG.SW	Supplier and customer	CH	-0.04
Ipsen IPN.PA	Supplier and customer	FR	-0.67
Forest City Realty Trust Inc FCE.A	Supplier	US	—
University of Texas at Austin	Supplier and customer	US	—

Similar companies

Companies in the same industry as Blueprint Medicines

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.